PM
NARI

Prosight Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Prosight Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-130,000
Closed -$8.5M – 48
2023
Q3 		$8.5M Buy
130,000
+11,316
+10% +$712K 2.69% 12
2023
Q2 		$6.9M Buy
118,684
+56,603
+91% +$3.57M 2.02% 19
2023
Q1 		$3.83M Buy
+62,081
New +$3.72M 1.82% 22

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prosight Management's NARI Position: Q4 2023 in Review

Prosight Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2023, closing a stake of 130,000 shares — an estimated $8.5M sold.

Prosight Management first reported a position in NARI in Q1 2023 and held it in 3 quarters. The position peaked at $8.5M in Q3 2023. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

  • Prosight Management reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prosight Management sold 130,000 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $8.5M.
  • Prosight Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Prosight Management's Inari Medical, Inc. Common Stock position peaked at $8.5M in Q3 2023.
  • 252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on Prosight Management's 13F filing for Q4 2023, filed 14 Feb 2024.